On Sept. 4, PDL BioPharma, Inc. (NASDAQ:PDLI) announced that the adjusted conversion rate for the: 3.75% Convertible Senior Notes due May 1, 2015 (May 2015 Notes), is 167.9812 shares of common stock per $1,000 principal amount or approximately $5.95 per share, effective September 3, 2014;. PDL BioPharma, Inc. (NASDAQ:PDLI) belongs to Healthcare sector. Its net profit margin is 55.70% and weekly performance is -2.21%. On … Continue reading Trending Tickers : PDL BioPharma, Inc. (NASDAQ:PDLI), F5 Networks, Inc. (NASDAQ:FFIV), Zynga Inc (NASDAQ:ZNGA), Evolution Petroleum Corp. (NYSEMKT:EPM), SigmaTron International Inc. (NASDAQ:SGMA)